Notice Regarding the 340B Drug Pricing Program; Children's Hospitals, 37250-37252 [E7-13239]
Download as PDF
37250
Federal Register / Vol. 72, No. 130 / Monday, July 9, 2007 / Notices
ESTIMATES OF ANNUALIZED HOUR BURDEN—Continued
Number of
respondents
Form
Responses
per respondents
Total
responses
Hours per
response
Total burden
hours
Heart/Lung Candidate Registration .....................................
Thoracic Registration ...........................................................
Thoracic Follow-up ...............................................................
Kidney Candidate Registration ............................................
Kidney Registration ..............................................................
Kidney Follow-up .................................................................
Liver Candidate Registration ...............................................
Liver Registration .................................................................
Liver Follow-up .....................................................................
Kidney/Pancreas Candidate Registration ............................
Kidney/Pancreas Registration ..............................................
Kidney/Pancreas Follow-up .................................................
Pancreas Candidate Registration ........................................
Pancreas Registration ..........................................................
Pancreas Follow-up .............................................................
Intestine Candidate Registration ..........................................
Intestine Registration ...........................................................
Intestine Follow-up ...............................................................
Post Transplant Malignancy ................................................
59
135
135
250
250
250
125
125
125
146
146
146
146
146
146
45
45
45
711
1
27
229
133
69
544
89
54
383
12
7
65
7
3
23
8
4
17
6
59
3,645
30,915
33,250
17,250
136,000
11,125
6,750
47,875
1,752
1,022
9,490
1,022
438
3,358
360
180
765
4,266
0.2800
0.4400
0.4130
0.2800
0.4400
0.3332
0.2800
0.4000
0.3336
0.2800
0.5300
0.5027
0.2800
0.4400
0.4133
0.2400
0.5300
0.5059
0.0800
16.5200
1,603.8000
12,767.8950
9,310.0000
7,590.0000
45,315.2000
3,115.0000
2,700.0000
15,971.1000
490.5600
541.6600
4,770.6230
286.1600
192.7200
1,387.8614
86.4000
95.4000
387.0135
341.2800
Total ..............................................................................
923
........................
388,628
........................
131,472.4329
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
Karen Matsuoka, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: June 28, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7–13170 Filed 7–6–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice Regarding the 340B Drug
Pricing Program; Children’s Hospitals
Health Resources and Services
Administration, HHS.
ACTION: Notice.
rwilkins on PROD1PC63 with NOTICES
AGENCY:
SUMMARY: Section 340B of the Public
Health Service Act (section 340B) and
section 1927(a) of the Social Security
Act (section 1927(a)) implement a drug
pricing program in which manufacturers
who sell covered outpatient drugs to
covered entities must agree to charge a
price that will not exceed an amount
determined under a statutory formula.
Section 6004 of the Deficit Reduction
Act of 2005 (Pub. L. 109–171) (section
6004) added children’s hospitals to the
list of covered entities eligible to access
VerDate Aug<31>2005
18:46 Jul 06, 2007
Jkt 211001
340B discounted drugs. The purpose of
this notice is to inform interested parties
of proposed guidelines regarding the
addition of children’s hospitals that
meet certain requirements, specifically:
(1) The process for the addition of
children’s hospitals to the 340B
Program; and (2) the obligation of
manufacturers to provide the statutorily
mandated discount to children’s
hospitals. These proposed guidelines
will not take effect until final guidelines
are issued.
DATES: The public is invited to comment
on the proposed guidelines by
September 7, 2007. After consideration
of the submitted comments, the Health
Resources and Services Administration
(HRSA) will issue the final guidelines.
ADDRESSES: Address all comments to
Mr. Bradford R. Lang, Public Health
Analyst, Office of Pharmacy Affairs
(OPA), Healthcare Systems Bureau
(HSB), HRSA, 5600 Fishers Lane,
Parklawn Building, Room 10C–03,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Mr.
Jimmy Mitchell, Director, OPA, HSB,
HRSA, 5600 Fishers Lane, Parklawn
Building, Room 10C–03, Rockville, MD
20857, or by telephone through the
Pharmacy Services Support Center at
1–800–628–6297.
SUPPLEMENTARY INFORMATION:
(A) Background
Section 602 of Public Law 102–585,
the Veterans Health Care Act of 1992,
enacted section 340B, Limitation on
Prices of Drugs Purchased by Covered
Entities and added certain
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
implementation provisions for the 340B
Program to section 1927(a) of the Social
Security Act. Section 340B contains the
majority of the requirements for covered
entities participating in the 340B
Program, while the relevant provisions
of section 1927(a) of the Social Security
Act provide primarily for the
requirement that manufacturers provide
the statutorily mandated discount to
covered entities.
Section 340B contains a list of
covered entities that are eligible to
receive discounts through the 340B
Program. The list includes entities such
as Federally Qualified Health Centers,
State-operated AIDS drug purchasing
assistance programs, and certain
disproportionate share hospitals.
Children’s hospitals were not included
as covered entities under section 340B
in the Veterans Health Care Act of 1992
as enacted.
Section 6004 added children’s
hospitals as covered entities eligible to
access 340B discounted drugs. To
accomplish this, section 6004 did not
amend section 340B (which contains
many of the requirements for covered
entities). Section 6004 amended section
1927(a) of the Social Security Act
(which primarily contains requirements
for manufacturers’ participation) to add
children’s hospitals to the 340B
Program.
To be eligible for the 340B Drug
Pricing Program, section 1927(a), as
amended by section 6004, requires
children’s hospitals to meet the
requirements of clauses (i) and (iii) of
section 340B(a)(4)(L) of the Public
Health Service Act, which contain
E:\FR\FM\09JYN1.SGM
09JYN1
Federal Register / Vol. 72, No. 130 / Monday, July 9, 2007 / Notices
provisions for State or local government
affiliations and non-participation in
group purchasing organizations. In
addition, children’s hospitals must meet
the requirements of clause (ii) of such
section, which contains requirements
for the provision of indigent care, if
such section ‘‘were applied by taking
into account the percentage of care
provided by the hospital to patients
eligible for medical assistance’’ under
Medicaid.
(B) Obligation of Manufacturers To
Provide 340B Discounts to Children’s
Hospitals
Section 1927(a)(5)(A) of the Social
Security Act requires manufacturers to
enter into agreements with the Secretary
that meet the requirements of section
340B with respect to covered outpatient
drugs purchased by a covered entity.
Section 1927(a)(5)(B), as amended by
section 6004, defines covered entities
for purposes of section 1927(a)(5) as
those covered entities listed in the
Public Health Service Act and certain
children’s hospitals. As section
1927(a)(5)(A) requires manufacturers to
enter into agreements ‘‘with respect to
covered outpatient drugs purchased by
a covered entity,’’ and covered entity is
defined as including children’s
hospitals for purposes of section 1927,
manufacturers are required to extend
340B pricing to eligible children’s
hospitals.
The Pharmaceutical Pricing
Agreements (PPA) between the
Secretary and each manufacturer require
manufacturers to provide 340B
discounted covered outpatient drugs to
covered entities. Given the clear
congressional intent in Section 6004 to
expand the category of covered entities,
the PPAs currently in place effectively
require manufacturers to provide 340B
discounts to children’s hospitals
without need for further amendment to
currently existing PPAs.
(C) Process for Admission of Children’s
Hospitals to the 340B Program
rwilkins on PROD1PC63 with NOTICES
(1) Children’s Hospitals Participation
Children’s hospitals participation in
the 340B Drug Pricing Program is
voluntary. Consistent with the
participation of other covered entities,
once a children’s hospital has elected to
participate in the program, it must wait
to enter or withdraw from the program
until the next official updating of the
340B covered entity database. OPA will
update this list two weeks before the
beginning of each calendar quarter.
Participating children’s hospitals must
comply with all program guidelines for
covered entities until the date they are
VerDate Aug<31>2005
16:59 Jul 06, 2007
Jkt 211001
removed from the 340B covered entity
database. OPA will accept applications
from children’s hospitals for entry into
the 340B Program as of the date of
publication of the final notice of these
guidelines.
(2) Certification by Children’s Hospitals
Prior to 340B Drug Pricing Program
Entry
As with other covered entities, prior
to entry into the 340B Drug Pricing
Program, children’s hospitals will be
required to provide OPA with a
certification regarding several different
program requirements.
As a threshold matter, a hospital
wishing to qualify for the 340B Program
as a children’s hospital must
demonstrate that the hospital is a
‘‘children’s hospital’’ as defined by
section 6004. Section 6004 requires that
a hospital wishing to qualify as a
children’s hospital covered entity must
(1) satisfy the definition of ‘‘children’s
hospital’’ contained in section
1886(d)(1)(B)(iii) of the Social Security
Act; and (2) meet minimum
requirements for the receipt of an
additional payment under Medicare
pursuant to section 1886(d)(5)(F)(i) of
the Social Security Act (if such clause
were applied by taking into account the
percentage of care provided by the
hospital to Medicaid patients). Given
the reliance of section 6004 on Medicare
payment provisions for the definition of
‘‘children’s hospital,’’ a hospital will
need to demonstrate that it has been
provided a Medicare provider number
identifying the hospital as a ‘‘children’s
hospital’’ (i.e., a hospital with a 3300
series Medicare provider number).
Prior to entry into the 340B Program,
a children’s hospital must certify that it
will abide by all the requirements of
section 340B that all other covered
entities abide by (e.g., prohibition on
resale of covered outpatient drugs;
prohibition on duplicate discounts or
rebates). While children’s hospitals are
not explicitly mentioned in section
340B, it is implicit in section 1927(a) of
the Social Security Act that children’s
hospitals abide by the requirements of
section 340B. Section 1927(a) provides
that manufacturers must have entered
into agreements with the Secretary that
meet the requirements of section 340B
and several of the provisions contained
in these agreements concern covered
entities’ compliance with provisions of
section 340B. Furthermore, it is within
the Secretary’s authority under section
340B to create guidelines necessary for
the implementation of the program.
Unless children’s hospitals are subject
to all of the same rules as other covered
entities, the inclusion of children’s
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
37251
hospitals in the 340B Program would be
difficult, if not impossible.
Prior to entry into the 340B Program
a children’s hospital must certify
compliance (along with the date of
compliance) with clauses (i), (ii), and
(iii) of section 340B(a)(4)(L) (in
accordance with section 1927(a)(5)(B) of
the Social Security Act). To comply
with section 340B(a)(4)(L)(i), a
children’s hospital will have to certify
(and include such supporting
documentation as requested by OPA)
that the children’s hospital is:
(1) Owned or operated by a unit of
State or local government;
(2) a public or private non-profit
corporation which is formally granted
governmental powers by a unit of State
or local government; or
(3) A private non-profit hospital
under contract with State or local
government to provide health care
services to low income individuals who
are not eligible for Medicare or
Medicaid.
To comply with section
340B(a)(4)(L)(ii), a children’s hospital
will have to certify (and include such
supporting documentation as requested
by OPA) that the children’s hospital:
(1) Is located in an urban area, has 100
or more beds, and can demonstrate that
its net inpatient care revenues
(excluding any of such revenues
attributable to Medicare), during the
cost reporting period in which the
discharges occur, for indigent care from
State and local government sources and
Medicaid exceed 30 percent of its total
of such net inpatient care revenues
during the period; or
(2) for the most recent cost reporting
period that ended before the calendar
quarter involved, had a disproportionate
share adjustment percentage (as
determined under section 1886(d)(5)(F)
of the Social Security Act) greater than
11.75 percent.
To comply with section
340B(a)(4)(L)(iii), a children’s hospital
will have to certify that the children’s
hospital will not participate in a group
purchasing organization or group
purchasing arrangement for covered
outpatient drugs as of the effective date
in the 340B covered entity database.
Prior to entry into the 340B Program,
OPA requires certification of a
children’s hospital’s compliance with
section 340B(a)(4)(L)(ii). In addition to
having a 3300 series Medicare provider
identification number, initially, OPA
will seek verification of compliance
based on the Medicare cost report
submitted by the children’s hospital to
the Centers for Medicare and Medicaid
Services (CMS). Given that children’s
hospitals are not eligible for the
E:\FR\FM\09JYN1.SGM
09JYN1
37252
Federal Register / Vol. 72, No. 130 / Monday, July 9, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES
prospective payment system, the
materials submitted by any particular
children’s hospital may not provide the
required verification. To the extent that
OPA is unable to obtain independent
verification, a children’s hospital will be
expected to verify that the children’s
hospital meets the requirements of
section 340B(a)(4)(L)(ii) if requested by
OPA.
OPA is considering whether it would
be appropriate to require a statement
from an independent auditor certifying
that a children’s hospital meets the
requirements of section 340B(a)(4)(L)(ii)
in those cases where there is no
established method of verification
analogous to that utilized to annually
certify DSH eligibility in the 340B Drug
Pricing Program. OPA invites comments
from stakeholders on the feasibility of
an independent auditor to verify
eligibility of children’s hospitals. OPA
also seeks comments from children’s
hospitals as to the relative burden that
an independent auditor statement may
entail and welcomes alternate proposals
as to how to best ensure the integrity of
the 340B Drug Pricing Program while
minimizing costs.
(3) Eligibility for Retroactive Discounts
Section 6004 indicates that the
amendment authorizing entry of
children’s hospitals into the 340B
Program ‘‘shall apply to drugs
purchased on or after the date of the
enactment of this Act.’’ Section 6004
was enacted on February 8, 2006.
Therefore, once they are admitted to the
340B Program, children’s hospitals are
eligible for 340B drug pricing retroactive
to February 8, 2006. However, a
children’s hospital will be eligible for
retroactive discounts only to the extent
that it has satisfied all requirements for
participation in the 340B program back
to the date discounts are requested.
Similar to when the 340B Program
was first started, children’s hospitals
that participate in the program will be
eligible for retroactive discounts. Until
120 days after publication of the final
notice, children’s hospitals which have
been included in OPA’s database of
covered entities may request retroactive
discounts (discounts, rebates, or account
credit) from pharmaceutical
manufacturers for covered outpatient
drugs that satisfy all the following
conditions:
(1) The covered outpatient drugs must
have been purchased on or after
February 8, 2006;
(2) The covered outpatient drugs must
not have generated Medicaid rebates
(the children’s hospital must have
appropriate documentation to
demonstrate this); and
VerDate Aug<31>2005
16:59 Jul 06, 2007
Jkt 211001
(3) The covered outpatient drugs must
have been purchased on or after the date
on which the children’s hospital
satisfied all requirements for
participation in the 340B Program as
outlined in section (C)(2) of this notice.
In order to satisfy the last condition
listed above, a children’s hospital must
be able to demonstrate, at a minimum,
that as required by section
340B(a)(4)(L)(iii) of the Public Health
Service Act the children’s hospital did
not have a group purchasing agreement
for covered outpatient drugs and
satisfied the requirements of section
340B(a)(4)(L)(i) and 340B(a)(4)(L)(ii) at
the time the covered outpatient drugs
for which rebates are requested were
purchased.
Dated: June 29, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–13239 Filed 7–6–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
American Indians Into Medicine; Notice
of Competitive Grant Applications for
American Indians Into Medicine
Program
Announcement Type: Initial.
Funding Opportunity Number: HHS–
2007–IHS–INMED–0001.
CFDA Number: 93.970.
Key Dates:
Application Deadline: August 16,
2007.
Application Review: August 21, 2007.
Application Notification: August 27,
2007.
Anticipated Award Start Date:
September 1, 2007.
I. Funding Opportunity Description
The Indian Health Service (IHS)
announces that competitive grant
applications are being accepted for the
American Indians into Medicine
Program. These grants are established
under the authority of 25 U.S.C.
1616g(a) of the Indian Health Care
Improvement Act, as amended by Public
Law (Pub. L.) 102–573. The purpose of
the Indians into Medicine program is to
augment the number of American
Indian/Alaska Native (AI/AN) health
professionals serving AI/AN by
encouraging them to enter the health
professions and removing the multiple
barriers to their entrance into IHS and
private practice among AI/AN
communities. For the purpose of
maintaining and expanding the Indians
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
into Medicine program two grants will
be funded. One grant will be funded at
$300,000 and a second grant will be
funded at $60,000. Each grant will have
different criteria which will be listed
separately in this announcement.
This program is described at 93.970 in
the Catalog of Federal Domestic
Assistance. The Public Health Service
(PHS) is committed to achieving the
health promotion and disease
prevention objectives of Healthy People
2010, a PHS-led activity for setting
priority areas. This program
announcement is related to the priority
area of Educational and Communitybased programs. Potential applicants
may obtain a copy of Healthy People
2010, summary report in print, Stock
No. 017–001–00547–9, or via CD–ROM,
Stock No. 107–001–00549–5, through
the Superintendent of Documents,
Government Printing Office, P.O. Box
371954, Pittsburgh, PA 15250–7945,
(202) 512–1800. You may access this
information via the Internet at the
following Web site: www.health.gov/
healthypeople.
The PHS strongly encourages all grant
and contract recipients to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
PHS mission to protect and advance the
physical and mental health of the
American people.
II. Award Information
Type of Awards: Grant.
Estimated Funds Available: The total
amount identified for Fiscal Year 2007
is $360,000 to provide support for an
estimated two awards. The awards are
for 12 months in duration and the
awards are approximately $300,000 for
one grant award and $60,000 for a
second grant award. Future awards
issued under this announcement are
subject to the availability of funds.
Anticipated Number of Awards: An
estimated two awards will be made
under the program. Applicants may
apply for both grants but only one grant
will be awarded per applicant.
Project Period: 36 months = $300,000
grant award; 12 months = $60,000 grant
award.
Award Amount: $300,000, per year for
one grant award and $60,000, per year
for a second grant award.
E:\FR\FM\09JYN1.SGM
09JYN1
Agencies
[Federal Register Volume 72, Number 130 (Monday, July 9, 2007)]
[Notices]
[Pages 37250-37252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13239]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Notice Regarding the 340B Drug Pricing Program; Children's
Hospitals
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Section 340B of the Public Health Service Act (section 340B)
and section 1927(a) of the Social Security Act (section 1927(a))
implement a drug pricing program in which manufacturers who sell
covered outpatient drugs to covered entities must agree to charge a
price that will not exceed an amount determined under a statutory
formula. Section 6004 of the Deficit Reduction Act of 2005 (Pub. L.
109-171) (section 6004) added children's hospitals to the list of
covered entities eligible to access 340B discounted drugs. The purpose
of this notice is to inform interested parties of proposed guidelines
regarding the addition of children's hospitals that meet certain
requirements, specifically: (1) The process for the addition of
children's hospitals to the 340B Program; and (2) the obligation of
manufacturers to provide the statutorily mandated discount to
children's hospitals. These proposed guidelines will not take effect
until final guidelines are issued.
DATES: The public is invited to comment on the proposed guidelines by
September 7, 2007. After consideration of the submitted comments, the
Health Resources and Services Administration (HRSA) will issue the
final guidelines.
ADDRESSES: Address all comments to Mr. Bradford R. Lang, Public Health
Analyst, Office of Pharmacy Affairs (OPA), Healthcare Systems Bureau
(HSB), HRSA, 5600 Fishers Lane, Parklawn Building, Room 10C-03,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Mr. Jimmy Mitchell, Director, OPA,
HSB, HRSA, 5600 Fishers Lane, Parklawn Building, Room 10C-03,
Rockville, MD 20857, or by telephone through the Pharmacy Services
Support Center at 1-800-628-6297.
SUPPLEMENTARY INFORMATION:
(A) Background
Section 602 of Public Law 102-585, the Veterans Health Care Act of
1992, enacted section 340B, Limitation on Prices of Drugs Purchased by
Covered Entities and added certain implementation provisions for the
340B Program to section 1927(a) of the Social Security Act. Section
340B contains the majority of the requirements for covered entities
participating in the 340B Program, while the relevant provisions of
section 1927(a) of the Social Security Act provide primarily for the
requirement that manufacturers provide the statutorily mandated
discount to covered entities.
Section 340B contains a list of covered entities that are eligible
to receive discounts through the 340B Program. The list includes
entities such as Federally Qualified Health Centers, State-operated
AIDS drug purchasing assistance programs, and certain disproportionate
share hospitals. Children's hospitals were not included as covered
entities under section 340B in the Veterans Health Care Act of 1992 as
enacted.
Section 6004 added children's hospitals as covered entities
eligible to access 340B discounted drugs. To accomplish this, section
6004 did not amend section 340B (which contains many of the
requirements for covered entities). Section 6004 amended section
1927(a) of the Social Security Act (which primarily contains
requirements for manufacturers' participation) to add children's
hospitals to the 340B Program.
To be eligible for the 340B Drug Pricing Program, section 1927(a),
as amended by section 6004, requires children's hospitals to meet the
requirements of clauses (i) and (iii) of section 340B(a)(4)(L) of the
Public Health Service Act, which contain
[[Page 37251]]
provisions for State or local government affiliations and non-
participation in group purchasing organizations. In addition,
children's hospitals must meet the requirements of clause (ii) of such
section, which contains requirements for the provision of indigent
care, if such section ``were applied by taking into account the
percentage of care provided by the hospital to patients eligible for
medical assistance'' under Medicaid.
(B) Obligation of Manufacturers To Provide 340B Discounts to Children's
Hospitals
Section 1927(a)(5)(A) of the Social Security Act requires
manufacturers to enter into agreements with the Secretary that meet the
requirements of section 340B with respect to covered outpatient drugs
purchased by a covered entity. Section 1927(a)(5)(B), as amended by
section 6004, defines covered entities for purposes of section
1927(a)(5) as those covered entities listed in the Public Health
Service Act and certain children's hospitals. As section 1927(a)(5)(A)
requires manufacturers to enter into agreements ``with respect to
covered outpatient drugs purchased by a covered entity,'' and covered
entity is defined as including children's hospitals for purposes of
section 1927, manufacturers are required to extend 340B pricing to
eligible children's hospitals.
The Pharmaceutical Pricing Agreements (PPA) between the Secretary
and each manufacturer require manufacturers to provide 340B discounted
covered outpatient drugs to covered entities. Given the clear
congressional intent in Section 6004 to expand the category of covered
entities, the PPAs currently in place effectively require manufacturers
to provide 340B discounts to children's hospitals without need for
further amendment to currently existing PPAs.
(C) Process for Admission of Children's Hospitals to the 340B Program
(1) Children's Hospitals Participation
Children's hospitals participation in the 340B Drug Pricing Program
is voluntary. Consistent with the participation of other covered
entities, once a children's hospital has elected to participate in the
program, it must wait to enter or withdraw from the program until the
next official updating of the 340B covered entity database. OPA will
update this list two weeks before the beginning of each calendar
quarter. Participating children's hospitals must comply with all
program guidelines for covered entities until the date they are removed
from the 340B covered entity database. OPA will accept applications
from children's hospitals for entry into the 340B Program as of the
date of publication of the final notice of these guidelines.
(2) Certification by Children's Hospitals Prior to 340B Drug Pricing
Program Entry
As with other covered entities, prior to entry into the 340B Drug
Pricing Program, children's hospitals will be required to provide OPA
with a certification regarding several different program requirements.
As a threshold matter, a hospital wishing to qualify for the 340B
Program as a children's hospital must demonstrate that the hospital is
a ``children's hospital'' as defined by section 6004. Section 6004
requires that a hospital wishing to qualify as a children's hospital
covered entity must (1) satisfy the definition of ``children's
hospital'' contained in section 1886(d)(1)(B)(iii) of the Social
Security Act; and (2) meet minimum requirements for the receipt of an
additional payment under Medicare pursuant to section 1886(d)(5)(F)(i)
of the Social Security Act (if such clause were applied by taking into
account the percentage of care provided by the hospital to Medicaid
patients). Given the reliance of section 6004 on Medicare payment
provisions for the definition of ``children's hospital,'' a hospital
will need to demonstrate that it has been provided a Medicare provider
number identifying the hospital as a ``children's hospital'' (i.e., a
hospital with a 3300 series Medicare provider number).
Prior to entry into the 340B Program, a children's hospital must
certify that it will abide by all the requirements of section 340B that
all other covered entities abide by (e.g., prohibition on resale of
covered outpatient drugs; prohibition on duplicate discounts or
rebates). While children's hospitals are not explicitly mentioned in
section 340B, it is implicit in section 1927(a) of the Social Security
Act that children's hospitals abide by the requirements of section
340B. Section 1927(a) provides that manufacturers must have entered
into agreements with the Secretary that meet the requirements of
section 340B and several of the provisions contained in these
agreements concern covered entities' compliance with provisions of
section 340B. Furthermore, it is within the Secretary's authority under
section 340B to create guidelines necessary for the implementation of
the program. Unless children's hospitals are subject to all of the same
rules as other covered entities, the inclusion of children's hospitals
in the 340B Program would be difficult, if not impossible.
Prior to entry into the 340B Program a children's hospital must
certify compliance (along with the date of compliance) with clauses
(i), (ii), and (iii) of section 340B(a)(4)(L) (in accordance with
section 1927(a)(5)(B) of the Social Security Act). To comply with
section 340B(a)(4)(L)(i), a children's hospital will have to certify
(and include such supporting documentation as requested by OPA) that
the children's hospital is:
(1) Owned or operated by a unit of State or local government;
(2) a public or private non-profit corporation which is formally
granted governmental powers by a unit of State or local government; or
(3) A private non-profit hospital under contract with State or
local government to provide health care services to low income
individuals who are not eligible for Medicare or Medicaid.
To comply with section 340B(a)(4)(L)(ii), a children's hospital
will have to certify (and include such supporting documentation as
requested by OPA) that the children's hospital:
(1) Is located in an urban area, has 100 or more beds, and can
demonstrate that its net inpatient care revenues (excluding any of such
revenues attributable to Medicare), during the cost reporting period in
which the discharges occur, for indigent care from State and local
government sources and Medicaid exceed 30 percent of its total of such
net inpatient care revenues during the period; or
(2) for the most recent cost reporting period that ended before the
calendar quarter involved, had a disproportionate share adjustment
percentage (as determined under section 1886(d)(5)(F) of the Social
Security Act) greater than 11.75 percent.
To comply with section 340B(a)(4)(L)(iii), a children's hospital
will have to certify that the children's hospital will not participate
in a group purchasing organization or group purchasing arrangement for
covered outpatient drugs as of the effective date in the 340B covered
entity database.
Prior to entry into the 340B Program, OPA requires certification of
a children's hospital's compliance with section 340B(a)(4)(L)(ii). In
addition to having a 3300 series Medicare provider identification
number, initially, OPA will seek verification of compliance based on
the Medicare cost report submitted by the children's hospital to the
Centers for Medicare and Medicaid Services (CMS). Given that children's
hospitals are not eligible for the
[[Page 37252]]
prospective payment system, the materials submitted by any particular
children's hospital may not provide the required verification. To the
extent that OPA is unable to obtain independent verification, a
children's hospital will be expected to verify that the children's
hospital meets the requirements of section 340B(a)(4)(L)(ii) if
requested by OPA.
OPA is considering whether it would be appropriate to require a
statement from an independent auditor certifying that a children's
hospital meets the requirements of section 340B(a)(4)(L)(ii) in those
cases where there is no established method of verification analogous to
that utilized to annually certify DSH eligibility in the 340B Drug
Pricing Program. OPA invites comments from stakeholders on the
feasibility of an independent auditor to verify eligibility of
children's hospitals. OPA also seeks comments from children's hospitals
as to the relative burden that an independent auditor statement may
entail and welcomes alternate proposals as to how to best ensure the
integrity of the 340B Drug Pricing Program while minimizing costs.
(3) Eligibility for Retroactive Discounts
Section 6004 indicates that the amendment authorizing entry of
children's hospitals into the 340B Program ``shall apply to drugs
purchased on or after the date of the enactment of this Act.'' Section
6004 was enacted on February 8, 2006. Therefore, once they are admitted
to the 340B Program, children's hospitals are eligible for 340B drug
pricing retroactive to February 8, 2006. However, a children's hospital
will be eligible for retroactive discounts only to the extent that it
has satisfied all requirements for participation in the 340B program
back to the date discounts are requested.
Similar to when the 340B Program was first started, children's
hospitals that participate in the program will be eligible for
retroactive discounts. Until 120 days after publication of the final
notice, children's hospitals which have been included in OPA's database
of covered entities may request retroactive discounts (discounts,
rebates, or account credit) from pharmaceutical manufacturers for
covered outpatient drugs that satisfy all the following conditions:
(1) The covered outpatient drugs must have been purchased on or
after February 8, 2006;
(2) The covered outpatient drugs must not have generated Medicaid
rebates (the children's hospital must have appropriate documentation to
demonstrate this); and
(3) The covered outpatient drugs must have been purchased on or
after the date on which the children's hospital satisfied all
requirements for participation in the 340B Program as outlined in
section (C)(2) of this notice.
In order to satisfy the last condition listed above, a children's
hospital must be able to demonstrate, at a minimum, that as required by
section 340B(a)(4)(L)(iii) of the Public Health Service Act the
children's hospital did not have a group purchasing agreement for
covered outpatient drugs and satisfied the requirements of section
340B(a)(4)(L)(i) and 340B(a)(4)(L)(ii) at the time the covered
outpatient drugs for which rebates are requested were purchased.
Dated: June 29, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7-13239 Filed 7-6-07; 8:45 am]
BILLING CODE 4165-15-P